[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590631":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":48,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":10,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Leiden University Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ACHD patients with CRT",null,"All participants included in the registry have to have a congenital heart defect, be ≥ 18 years old and have to have a CRT pacemaker or defibrillator",[13],"Device: Cardiac resynchronization therapy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Cardiac resynchronization therapy","Cardiac resynchronization therapy pacemaker or defibrillator with a transvenous or epicardial systemic ventricle lead",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Anastasia D. Egorova, MD, PhD","CONTACT","+31 71 5262020","a.egorova@lumc.nl",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Leiden University Medical Center (LUMC)","RECRUITING","Leiden","South Holland","2333ZA","Netherlands","NL",{"type":36,"coordinates":37},"Point",[38,39],4.49306,52.15833,{"lat":39,"lon":38},[42,43,46],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},{"name":44,"role":45,"phone":10,"phoneExt":10,"email":10},"Bert A.C. Zwaenepoel, MD","SUB_INVESTIGATOR",{"name":47,"role":45,"phone":10,"phoneExt":10,"email":10},"Ralph M.L. Neijenhuis, MD",{"type":49,"investigatorFullName":22,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","MD, PhD","100590631","real-world-data-on-the-effects-of-cardiac-resynchronization-therapy-in-adult-patients-with-congenital-heart-disease-100590631",false,"NCT06969924","Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease","RECORD-CHD","Inclusion Criteria:\n\n* ACHD patients who underwent CRT implantation\n\nExclusion Criteria:\n\n* Less than 18 years old on the moment of CRT implantation\n* Patient objection to the use of retrospective data","ALL","18 Years",{"count":61,"type":62},100,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate the real-world effects of cardiac resynchronization therapy (CRT) in adult patients with congenital heart disease (ACHD). Specifically, it seeks to determine whether CRT improves clinical outcomes in this unique patient population and to identify factors associated with a favorable response to therapy.",[66],"Adult Congenital Heart Disease",[68,17,69,70,71,72],"Adult congenital heart disease","ACHD","CRT","Heart failure","HF","2025-05-13",{"date":75,"type":76},"2025-05-14","ACTUAL",{"date":78,"type":76},"2014-01-01",{"date":80,"type":62},"2028-12-31",{"name":5,"class":6},1]